Resources

Recent study explores link between disease and psychological well-being in older adults.

A new study shows an association between nerve and gum diseases in patients with diabetes.

Study shows at least one urologic complication was experienced during the course of seven years.

Can neuromodulation prevent the onset of metabolic dysfunction associated with the onset of diabetes?

What proportion of Americans age 45 y and older have self-reported memory problems?

Follow the link for the answer.

In your opinion, which diabetes patients are the best candidates for CGM?

- Patients on more than five diabetes medications
- Patients unable to achieve their HbA1c goal despite focused efforts
- Patients with frequent or extreme glucose excursions (>200 mg/dL, within day or day-to-day)
- or All of the above?

Follow the link to see how you and your colleagues compare.

In this Exclusive Interview transcript, Scott Isaacs talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston about using meal replacements for obesity treatment.

What is a SGLT2 Inhibitor? Sodium-glucose co-transporter 2 (SGLT2) inhibitors, also called gliflozin drugs,  are a new class of diabetic medications indicated for the treatment of type 2 diabetes. They have also been found to show cardiac benefits in patients with diabetes, and are being studied for possible use in type 1 diabetes. They work by reducing the absorption of glucose via the kidneys so that excess glucose is excreted through urination.

You may have read Dave Joffe's Editor's Note on the relative risk of developing diabetes and how sometimes patients use it as an excuse for having diabetes. Although we don't like to blame patients, it is true some people do think and say, "Why try? I have a family history of diabetes. I'm sure to get it too." Well, we know that isn't 100% true. Hopefully we work with our patients to help prevent or delay type 2 diabetes.

Scott Isaacs, M.D., F.A.C.P., F.A.C.E. is a board-certified endocrinologist and obesity medicine specialist in Atlanta, Georgia, and a faculty member at Emory University School of Medicine. He is a medical expert for ABC Television Networks and the medical director for the HMR Program for Weight Management at Atlanta Endocrine Associates. Since 1998, Dr. Isaacs has focused his medical practice on obesity medicine and endocrinology. Dr. Isaacs attended Emory College and Emory University School of Medicine, continuing for his residency in Internal Medicine and Fellowship in Endocrinology, Lipids, Diabetes and Metabolism. Dr. Isaacs is a Fellow of the American College of Physicians and the American College of Endocrinology.  Dr. Isaacs is past president of the Georgia Chapter of the American Association of Clinical Endocrinologists and currently serves on the national AACE board of directors and chairs the patient education and awareness committee. Dr. Isaacs is past president of the Atlanta Chapter of the Atlanta Diabetes Association.